Health X Platform Ltd.
•₹ 300.85-0.51%
2026-08-21
ABOUT
KEY POINTS
Revenue Breakup Mar 2025 • Digital Pharmacy & Healthcare Store: 97.9% • Financial and Investment Management Activities: 2.1%
PROS
- Asset quality is healthy - gross NPA of just 0.0%
- Company has delivered good sales growth of 23.6% CAGR over last 5 years
- Company generates healthy free cash flow
CONS
- Company is loss-making at the operating / net level
- Capital adequacy is tight at 0.0% - limited headroom to grow
- Recent results are weak - TTM profit is down 129.5% versus prior year
- Company has a low return on capital employed of -15.8%
- Company has a low return on equity of -10.2% over last 3 years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | BAJFINANCE | 1078.60 | 33.07 | 671531.43 | 0.56 | 6080.60 | 27.60 | 23165.45 | 20.37 | 10.87 | 70.70 |
| 2. | SHRIRAMFIN | 1104.90 | 22.97 | 259981.15 | 0.98 | 3452.77 | 59.90 | 13400.43 | 17.46 | 11.49 | 74.63 |
| 3. | JIOFIN | 242.70 | 77.55 | 160258.25 | 0.25 | 830.25 | 155.73 | 2004.47 | 227.28 | 2.11 | 69.71 |
| 4. | CHOLAFIN | 1866.25 | 27.72 | 159390.07 | 0.11 | 1656.22 | 45.56 | 8856.29 | 21.89 | 9.70 | 70.07 |
| 5. | TATACAP | 365.15 | 28.68 | 155001.39 | 0.16 | 16281.80 | 1464.16 | 88219.30 | 1051.00 | 8.66 | 75.72 |
| 6. | BAJAJHLDNG | 11322.85 | 14.23 | 126015.97 | 1.72 | 2708.08 | -92.27 | 394.33 | 23.34 | 14.81 | 684.72 |
| 7. | MUTHOOTFIN | 2859.20 | 10.09 | 114787.87 | 1.05 | 2824.84 | 43.08 | 8671.60 | 36.25 | 15.87 | 83.76 |
| 8. | ABCAPITAL | 396.75 | 26.46 | 108592.29 | 0.00 | 1223.85 | 43.85 | 12179.54 | 137.84 | 8.82 | 41.91 |
| 9. | LTF | 315.00 | 24.80 | 78940.44 | 0.87 | 915.99 | 30.70 | 5212.92 | 22.38 | 8.54 | 62.13 |
| 10. | SBICARD | 626.30 | 0.00 | 59601.37 | 0.40 | 664.44 | 19.51 | 5040.55 | 7.60 | 11.75 | 29.83 |
| 11. | HDBFS | 681.15 | 26.00 | 56579.31 | 0.59 | 785.20 | 38.31 | 4937.90 | 18.71 | 9.09 | 57.98 |
| 12. | HEALTHX | 317.00 | 0.00 | 1008.39 | 0.00 | 1.99 | -92.53 | 446.85 | 2146.61 | -28.40 | -1.87 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 336 | 353 | 374 | 307 | 7 | 273 | 1 | 286 | 20 | 301 | 4 | 374 | 447 | |
| 327 | 355 | 371 | 317 | 273 | 278 | 305 | 311 | 292 | 324 | 356 | 399 | 458 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 12 | 10 | 20 | 18 | 28 | 22 | -12 | 22 | 25 | 6 | 14 | 14 | 13 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 2 | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| 19 | 11 | 21 | 5 | 25 | -174 | -39 | -5 | 30 | -19 | 1 | -15 | 2 | |
| Tax % | -28.85% | -53.38% | 0.67% | -583.23% | -102.80% | 13.17% | -1.99% | 479.70% | 11.92% | 17.17% | 59.78% | 12.54% | -0.61% |
| Net Profit | 0 | 0 | 0 | 0 | 41 | -155 | -38 | 18 | 27 | -15 | 0 | -13 | 2 |
| 0 | -2 | -0 | 5 | 10 | -34 | -8 | 4 | 8 | -4 | 0 | -4 | 0 | |
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 336
- 327
- Operating Profit
- —
- OPM %
- —
- Other Income
- 12
- Interest
- 0
- Depreciation
- 2
- 19
- Tax %
- -28.85%
- Net Profit
- 0
- 0
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 353
- 355
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 0
- Depreciation
- 2
- 11
- Tax %
- -53.38%
- Net Profit
- 0
- -2
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 374
- 371
- Operating Profit
- —
- OPM %
- —
- Other Income
- 20
- Interest
- 0
- Depreciation
- 2
- 21
- Tax %
- 0.67%
- Net Profit
- 0
- -0
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 307
- 317
- Operating Profit
- —
- OPM %
- —
- Other Income
- 18
- Interest
- 0
- Depreciation
- 3
- 5
- Tax %
- -583.23%
- Net Profit
- 0
- 5
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 7
- 273
- Operating Profit
- —
- OPM %
- —
- Other Income
- 28
- Interest
- 0
- Depreciation
- 2
- 25
- Tax %
- -102.80%
- Net Profit
- 41
- 10
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 273
- 278
- Operating Profit
- —
- OPM %
- —
- Other Income
- 22
- Interest
- 0
- Depreciation
- 1
- -174
- Tax %
- 13.17%
- Net Profit
- -155
- -34
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 1
- 305
- Operating Profit
- —
- OPM %
- —
- Other Income
- -12
- Interest
- 0
- Depreciation
- 1
- -39
- Tax %
- -1.99%
- Net Profit
- -38
- -8
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 286
- 311
- Operating Profit
- —
- OPM %
- —
- Other Income
- 22
- Interest
- 0
- Depreciation
- 1
- -5
- Tax %
- 479.70%
- Net Profit
- 18
- 4
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 20
- 292
- Operating Profit
- —
- OPM %
- —
- Other Income
- 25
- Interest
- 0
- Depreciation
- 1
- 30
- Tax %
- 11.92%
- Net Profit
- 27
- 8
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 301
- 324
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 0
- Depreciation
- 1
- -19
- Tax %
- 17.17%
- Net Profit
- -15
- -4
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 4
- 356
- Operating Profit
- —
- OPM %
- —
- Other Income
- 14
- Interest
- 0
- Depreciation
- 2
- 1
- Tax %
- 59.78%
- Net Profit
- 0
- 0
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 374
- 399
- Operating Profit
- —
- OPM %
- —
- Other Income
- 14
- Interest
- 0
- Depreciation
- 2
- -15
- Tax %
- 12.54%
- Net Profit
- -13
- -4
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 447
- 458
- Operating Profit
- —
- OPM %
- —
- Other Income
- 13
- Interest
- 1
- Depreciation
- 2
- 2
- Tax %
- -0.61%
- Net Profit
- 2
- 0
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 32
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 86 | 133 | 159 | 220 | 385 | 548 | 631 | 1,040 | 1,376 | 1,111 | 1,126 | |
| 117 | 155 | 174 | 255 | 440 | 561 | 678 | 1,083 | 1,370 | 1,167 | 1,537 | |
| Operating Profit | -28 | -18 | -12 | -33 | -51 | -9 | -35 | -19 | 66 | 4 | — |
| OPM % | -33 | -14 | -8 | -15 | -13 | -2 | -6 | -2 | 5 | 0 | — |
| Other Income | 3 | 4 | 3 | 2 | 3 | 3 | 12 | 24 | 60 | 60 | 46 |
| Interest | 1 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 | 0 | 1 |
| Depreciation | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 | 6 | 7 |
| -37 | -28 | -12 | -42 | -58 | -16 | 1,109 | -122 | -30 | -204 | -31 | |
| Tax % | 1 | -2 | -19 | -3 | 9 | -4 | 22 | 19 | 119 | 34 | 15 |
| Net Profit | -37 | -29 | -15 | -43 | -52 | -17 | 865 | -99 | 6 | -134 | -26 |
| EPS | 0 | 0 | 0 | 0 | 0 | -3 | 197 | -23 | 3 | -29 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | -0 | -0 | 3 | 5 | 13 | 7 | -238 | 27 | 3 | 42 | -1 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -12 | -9 | -4 | -12 | -12 | -3 | 197 | -23 | 3 | -29 | — |
| Minority Interest | -0 | -0 | 3 | 5 | 13 | 7 | -238 | 27 | 3 | 42 | -1 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -12 | -9 | -4 | -12 | -12 | -3 | 197 | -23 | 3 | -29 | — |
Mar 2016
- 86
- 117
- Operating Profit
- -28
- OPM %
- -33
- Other Income
- 3
- Interest
- 1
- Depreciation
- 7
- -37
- Tax %
- 1
- Net Profit
- -37
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -12
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -12
Mar 2017
- 133
- 155
- Operating Profit
- -18
- OPM %
- -14
- Other Income
- 4
- Interest
- 3
- Depreciation
- 7
- -28
- Tax %
- -2
- Net Profit
- -29
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -9
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -9
Mar 2018
- 159
- 174
- Operating Profit
- -12
- OPM %
- -8
- Other Income
- 3
- Interest
- 1
- Depreciation
- 6
- -12
- Tax %
- -19
- Net Profit
- -15
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 3
- Share of Associates
- 0
- Adjusted EPS
- -4
- Minority Interest
- 3
- Share of Associates
- 0
- Adjusted EPS
- -4
Mar 2019
- 220
- 255
- Operating Profit
- -33
- OPM %
- -15
- Other Income
- 2
- Interest
- 3
- Depreciation
- 6
- -42
- Tax %
- -3
- Net Profit
- -43
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 5
- Share of Associates
- 0
- Adjusted EPS
- -12
- Minority Interest
- 5
- Share of Associates
- 0
- Adjusted EPS
- -12
Mar 2020
- 385
- 440
- Operating Profit
- -51
- OPM %
- -13
- Other Income
- 3
- Interest
- 1
- Depreciation
- 5
- -58
- Tax %
- 9
- Net Profit
- -52
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 13
- Share of Associates
- 0
- Adjusted EPS
- -12
- Minority Interest
- 13
- Share of Associates
- 0
- Adjusted EPS
- -12
Mar 2021
- 548
- 561
- Operating Profit
- -9
- OPM %
- -2
- Other Income
- 3
- Interest
- 3
- Depreciation
- 4
- -16
- Tax %
- -4
- Net Profit
- -17
- EPS
- -3
- Dividend Payout %
- 0
- Minority Interest
- 7
- Share of Associates
- 0
- Adjusted EPS
- -3
- Minority Interest
- 7
- Share of Associates
- 0
- Adjusted EPS
- -3
Mar 2022
- 631
- 678
- Operating Profit
- -35
- OPM %
- -6
- Other Income
- 12
- Interest
- 3
- Depreciation
- 4
- 1,109
- Tax %
- 22
- Net Profit
- 865
- EPS
- 197
- Dividend Payout %
- 0
- Minority Interest
- -238
- Share of Associates
- 0
- Adjusted EPS
- 197
- Minority Interest
- -238
- Share of Associates
- 0
- Adjusted EPS
- 197
Mar 2023
- 1,040
- 1,083
- Operating Profit
- -19
- OPM %
- -2
- Other Income
- 24
- Interest
- 2
- Depreciation
- 8
- -122
- Tax %
- 19
- Net Profit
- -99
- EPS
- -23
- Dividend Payout %
- 0
- Minority Interest
- 27
- Share of Associates
- 0
- Adjusted EPS
- -23
- Minority Interest
- 27
- Share of Associates
- 0
- Adjusted EPS
- -23
Mar 2024
- 1,376
- 1,370
- Operating Profit
- 66
- OPM %
- 5
- Other Income
- 60
- Interest
- 1
- Depreciation
- 9
- -30
- Tax %
- 119
- Net Profit
- 6
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 3
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 3
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2025
- 1,111
- 1,167
- Operating Profit
- 4
- OPM %
- 0
- Other Income
- 60
- Interest
- 0
- Depreciation
- 6
- -204
- Tax %
- 34
- Net Profit
- -134
- EPS
- -29
- Dividend Payout %
- 0
- Minority Interest
- 42
- Share of Associates
- 0
- Adjusted EPS
- -29
- Minority Interest
- 42
- Share of Associates
- 0
- Adjusted EPS
- -29
TTM
- 1,126
- 1,537
- Operating Profit
- —
- OPM %
- —
- Other Income
- 46
- Interest
- 1
- Depreciation
- 7
- -31
- Tax %
- 15
- Net Profit
- -26
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 37%
- 5 Years:
- 24%
- 3 Years:
- 21%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- 4%
- 5 Years:
- 26%
- 3 Years:
- -10%
- Last Year:
- -19%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | |
| 186 | 158 | 144 | 106 | 173 | 163 | 790 | 717 | 726 | 638 | |
| 16 | 18 | 12 | 0 | 5 | 10 | 0 | 0 | 0 | 0 | |
| Trade Payables | 7 | 21 | 9 | 14 | 50 | 39 | 33 | 57 | 43 | 59 |
| 24 | 27 | 41 | 80 | 55 | 49 | 423 | 399 | 349 | 235 | |
| Total Liabilities | 265 | 256 | 238 | 232 | 316 | 293 | 1,278 | 1,204 | 1,149 | 963 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 126 | 125 | 117 | 116 | 114 | 110 | 93 | 104 | 108 | 100 | |
| Capital Work in Progress | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 |
| 10 | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 676 | 575 | |
| 16 | 24 | 28 | 33 | 77 | 77 | 114 | 181 | 116 | 110 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35 | 10 | |
| Cash & Bank | 13 | 34 | 13 | 7 | 18 | 13 | 212 | 195 | 47 | 12 |
| 100 | 57 | 33 | 39 | 51 | 49 | 192 | 210 | 168 | 145 | |
| Total Assets | 265 | 256 | 238 | 232 | 316 | 293 | 1,278 | 1,204 | 1,149 | 963 |
| Total Debt | 19 | 21 | 12 | 0 | 5 | 10 | 0 | 0 | 0 | 0 |
| Net Working Capital | 58 | 59 | 68 | 58 | 81 | 83 | 470 | 421 | 503 | 465 |
| Contingent Liabilities | 34 | 22 | 3 | 2 | 2 | 2 | 2 | 2 | 4 | 4 |
| Book Value per Share | 68.52 | 59.60 | 55.15 | 43.23 | 64.48 | 61.27 | 258.25 | 235.27 | 238.09 | 210.58 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 19 | 21 | 12 | 0 | 5 | 10 | 0 | 0 | 0 | 0 |
| Net Working Capital | 58 | 59 | 68 | 58 | 81 | 83 | 470 | 421 | 503 | 465 |
| Contingent Liabilities | 34 | 22 | 3 | 2 | 2 | 2 | 2 | 2 | 4 | 4 |
| Book Value per Share | 68.52 | 59.60 | 55.15 | 43.23 | 64.48 | 61.27 | 258.25 | 235.27 | 238.09 | 210.58 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2016
- 32
- 186
- 16
- Trade Payables
- 7
- 24
- Total Liabilities
- 265
- 126
- Capital Work in Progress
- 0
- 10
- 16
- 0
- Cash & Bank
- 13
- 100
- Total Assets
- 265
- Total Debt
- 19
- Net Working Capital
- 58
- Contingent Liabilities
- 34
- Book Value per Share
- 68.52
- Face Value
- 10.00
- Total Debt
- 19
- Net Working Capital
- 58
- Contingent Liabilities
- 34
- Book Value per Share
- 68.52
- Face Value
- 10.00
Mar 2017
- 32
- 158
- 18
- Trade Payables
- 21
- 27
- Total Liabilities
- 256
- 125
- Capital Work in Progress
- 0
- 17
- 24
- 0
- Cash & Bank
- 34
- 57
- Total Assets
- 256
- Total Debt
- 21
- Net Working Capital
- 59
- Contingent Liabilities
- 22
- Book Value per Share
- 59.60
- Face Value
- 10.00
- Total Debt
- 21
- Net Working Capital
- 59
- Contingent Liabilities
- 22
- Book Value per Share
- 59.60
- Face Value
- 10.00
Mar 2018
- 32
- 144
- 12
- Trade Payables
- 9
- 41
- Total Liabilities
- 238
- 117
- Capital Work in Progress
- 1
- 46
- 28
- 0
- Cash & Bank
- 13
- 33
- Total Assets
- 238
- Total Debt
- 12
- Net Working Capital
- 68
- Contingent Liabilities
- 3
- Book Value per Share
- 55.15
- Face Value
- 10.00
- Total Debt
- 12
- Net Working Capital
- 68
- Contingent Liabilities
- 3
- Book Value per Share
- 55.15
- Face Value
- 10.00
Mar 2019
- 32
- 106
- 0
- Trade Payables
- 14
- 80
- Total Liabilities
- 232
- 116
- Capital Work in Progress
- 1
- 36
- 33
- 0
- Cash & Bank
- 7
- 39
- Total Assets
- 232
- Total Debt
- 0
- Net Working Capital
- 58
- Contingent Liabilities
- 2
- Book Value per Share
- 43.23
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 58
- Contingent Liabilities
- 2
- Book Value per Share
- 43.23
- Face Value
- 10.00
Mar 2020
- 32
- 173
- 5
- Trade Payables
- 50
- 55
- Total Liabilities
- 316
- 114
- Capital Work in Progress
- 0
- 56
- 77
- 0
- Cash & Bank
- 18
- 51
- Total Assets
- 316
- Total Debt
- 5
- Net Working Capital
- 81
- Contingent Liabilities
- 2
- Book Value per Share
- 64.48
- Face Value
- 10.00
- Total Debt
- 5
- Net Working Capital
- 81
- Contingent Liabilities
- 2
- Book Value per Share
- 64.48
- Face Value
- 10.00
Mar 2021
- 32
- 163
- 10
- Trade Payables
- 39
- 49
- Total Liabilities
- 293
- 110
- Capital Work in Progress
- 0
- 43
- 77
- 0
- Cash & Bank
- 13
- 49
- Total Assets
- 293
- Total Debt
- 10
- Net Working Capital
- 83
- Contingent Liabilities
- 2
- Book Value per Share
- 61.27
- Face Value
- 10.00
- Total Debt
- 10
- Net Working Capital
- 83
- Contingent Liabilities
- 2
- Book Value per Share
- 61.27
- Face Value
- 10.00
Mar 2022
- 32
- 790
- 0
- Trade Payables
- 33
- 423
- Total Liabilities
- 1,278
- 93
- Capital Work in Progress
- 0
- 666
- 114
- 0
- Cash & Bank
- 212
- 192
- Total Assets
- 1,278
- Total Debt
- 0
- Net Working Capital
- 470
- Contingent Liabilities
- 2
- Book Value per Share
- 258.25
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 470
- Contingent Liabilities
- 2
- Book Value per Share
- 258.25
- Face Value
- 10.00
Mar 2023
- 32
- 717
- 0
- Trade Payables
- 57
- 399
- Total Liabilities
- 1,204
- 104
- Capital Work in Progress
- 1
- 513
- 181
- 0
- Cash & Bank
- 195
- 210
- Total Assets
- 1,204
- Total Debt
- 0
- Net Working Capital
- 421
- Contingent Liabilities
- 2
- Book Value per Share
- 235.27
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 421
- Contingent Liabilities
- 2
- Book Value per Share
- 235.27
- Face Value
- 10.00
Mar 2024
- 32
- 726
- 0
- Trade Payables
- 43
- 349
- Total Liabilities
- 1,149
- 108
- Capital Work in Progress
- 0
- 676
- 116
- 35
- Cash & Bank
- 47
- 168
- Total Assets
- 1,149
- Total Debt
- 0
- Net Working Capital
- 503
- Contingent Liabilities
- 4
- Book Value per Share
- 238.09
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 503
- Contingent Liabilities
- 4
- Book Value per Share
- 238.09
- Face Value
- 10.00
Mar 2025
- 32
- 638
- 0
- Trade Payables
- 59
- 235
- Total Liabilities
- 963
- 100
- Capital Work in Progress
- 10
- 575
- 110
- 10
- Cash & Bank
- 12
- 145
- Total Assets
- 963
- Total Debt
- 0
- Net Working Capital
- 465
- Contingent Liabilities
- 4
- Book Value per Share
- 210.58
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 465
- Contingent Liabilities
- 4
- Book Value per Share
- 210.58
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 36 | -17 | |
| Cash from Investing | -1 | 4 | 21 | -2 | -22 | 21 | 220 | 133 | -34 | -1 |
| Cash from Financing | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | -0 |
| -0 | 7 | 5 | -6 | 11 | -5 | 1 | 19 | -0 | -19 | |
| Free Cash Flow | -12 | -6 | -49 | -30 | -71 | -32 | -207 | -131 | 28 | -25 |
| OCF / Net Profit | 0.33 | 0.07 | 3.31 | 0.70 | 1.33 | 1.78 | -0.24 | 1.13 | 6.13 | 0.13 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -167 | -187 | -388 | -471 | -412 | -367 |
| OCF / Net Profit | 0.33 | 0.07 | 3.31 | 0.70 | 1.33 | 1.78 | -0.24 | 1.13 | 6.13 | 0.13 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -167 | -187 | -388 | -471 | -412 | -367 |
Mar 2016
- -12
- Cash from Investing
- -1
- Cash from Financing
- 13
- -0
- Free Cash Flow
- -12
- OCF / Net Profit
- 0.33
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.33
- Cumulative 5-Year FCF
- 0
Mar 2017
- -2
- Cash from Investing
- 4
- Cash from Financing
- 5
- 7
- Free Cash Flow
- -6
- OCF / Net Profit
- 0.07
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.07
- Cumulative 5-Year FCF
- 0
Mar 2018
- -49
- Cash from Investing
- 21
- Cash from Financing
- 33
- 5
- Free Cash Flow
- -49
- OCF / Net Profit
- 3.31
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 3.31
- Cumulative 5-Year FCF
- 0
Mar 2019
- -30
- Cash from Investing
- -2
- Cash from Financing
- 26
- -6
- Free Cash Flow
- -30
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- 0
Mar 2020
- -69
- Cash from Investing
- -22
- Cash from Financing
- 103
- 11
- Free Cash Flow
- -71
- OCF / Net Profit
- 1.33
- Cumulative 5-Year FCF
- -167
- OCF / Net Profit
- 1.33
- Cumulative 5-Year FCF
- -167
Mar 2021
- -31
- Cash from Investing
- 21
- Cash from Financing
- 4
- -5
- Free Cash Flow
- -32
- OCF / Net Profit
- 1.78
- Cumulative 5-Year FCF
- -187
- OCF / Net Profit
- 1.78
- Cumulative 5-Year FCF
- -187
Mar 2022
- -207
- Cash from Investing
- 220
- Cash from Financing
- -11
- 1
- Free Cash Flow
- -207
- OCF / Net Profit
- -0.24
- Cumulative 5-Year FCF
- -388
- OCF / Net Profit
- -0.24
- Cumulative 5-Year FCF
- -388
Mar 2023
- -112
- Cash from Investing
- 133
- Cash from Financing
- -2
- 19
- Free Cash Flow
- -131
- OCF / Net Profit
- 1.13
- Cumulative 5-Year FCF
- -471
- OCF / Net Profit
- 1.13
- Cumulative 5-Year FCF
- -471
Mar 2024
- 36
- Cash from Investing
- -34
- Cash from Financing
- -2
- -0
- Free Cash Flow
- 28
- OCF / Net Profit
- 6.13
- Cumulative 5-Year FCF
- -412
- OCF / Net Profit
- 6.13
- Cumulative 5-Year FCF
- -412
Mar 2025
- -17
- Cash from Investing
- -1
- Cash from Financing
- -0
- -19
- Free Cash Flow
- -25
- OCF / Net Profit
- 0.13
- Cumulative 5-Year FCF
- -367
- OCF / Net Profit
- 0.13
- Cumulative 5-Year FCF
- -367
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | -11.51 | -9.00 | -3.73 | -11.81 | -12.20 | -3.27 | 197.04 | -22.70 | 2.79 | -28.66 |
| Book Value (₹) | 68.52 | 59.60 | 55.15 | 43.23 | 64.48 | 61.27 | 258.25 | 235.27 | 238.09 | 210.58 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | -9.20 | -6.81 | -2.89 | -11.60 | -14.85 | -3.97 | 273.26 | -28.69 | 4.71 | -40.15 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | -32.67% | -13.64% | -7.84% | -14.93% | -13.36% | -1.69% | -5.59% | -1.85% | 0.40% | -5.04% |
| Net Margin % | -42.39% | -21.50% | -9.24% | -19.51% | -13.53% | -3.12% | 137.01% | -9.57% | 0.43% | -12.02% |
| ROE % | -15.47% | -14.02% | -8.07% | -27.39% | -30.43% | -8.55% | 170.23% | -12.67% | 0.78% | -18.71% |
| ROCE % | -14.29% | -11.07% | -5.71% | -23.50% | -31.37% | -6.48% | 214.79% | -15.23% | -3.88% | -28.40% |
| -12.92% | -10.97% | -5.96% | -18.25% | -19.05% | -5.62% | 110.18% | -8.02% | 0.50% | -12.64% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 44 | 38 | 26 | 10 | 11 | 9 | 10 | 10 | 9 | 7 |
| Inventory Days | 70 | 55 | 59 | 50 | 52 | 51 | 55 | 52 | 39 | 37 |
| Payable Days | 43 | 46 | 39 | 22 | 32 | 33 | 22 | 17 | 15 | 18 |
| 71 | 46 | 47 | 39 | 31 | 28 | 43 | 44 | 34 | 26 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.09x | 0.11x | 0.07x | 0.00x | 0.02x | 0.05x | 0.00x | 0.00x | 0.00x | 0.00x |
| Interest Coverage (x) | -25.73x | -8.58x | -13.69x | -13.01x | -38.31x | -5.27x | 333.22x | -62.15x | -27.52x | -694.10x |
| 2.85x | 2.22x | 3.35x | 3.34x | 2.18x | 2.31x | 7.72x | 4.52x | 7.53x | 5.71x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 78.39% | 54.08% | 19.91% | 37.90% | 75.41% | 42.23% | 15.18% | 64.68% | 32.30% | -19.25% |
| Operating Profit Growth % | -185.10% | 35.70% | 31.04% | -162.48% | -56.99% | 81.97% | -280.42% | 45.48% | 442.18% | -94.10% |
| Net Profit Growth % | -146.59% | 21.83% | 48.45% | -191.00% | -21.63% | 67.21% | 5161.50% | -111.50% | 105.88% | -2381.77% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 112.30% | -1126.34% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 108.60x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 1.27x | 1.15x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 13.93x | 195.23x |
Mar 2016
- EPS (₹)
- -11.51
- Book Value (₹)
- 68.52
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -9.20
- Operating Margin %
- -32.67%
- Net Margin %
- -42.39%
- ROE %
- -15.47%
- ROCE %
- -14.29%
- -12.92%
- Debtor Days
- 44
- Inventory Days
- 70
- Payable Days
- 43
- 71
- Debt to Equity (x)
- 0.09x
- Interest Coverage (x)
- -25.73x
- 2.85x
- Revenue Growth %
- 78.39%
- Operating Profit Growth %
- -185.10%
- Net Profit Growth %
- -146.59%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- -9.00
- Book Value (₹)
- 59.60
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -6.81
- Operating Margin %
- -13.64%
- Net Margin %
- -21.50%
- ROE %
- -14.02%
- ROCE %
- -11.07%
- -10.97%
- Debtor Days
- 38
- Inventory Days
- 55
- Payable Days
- 46
- 46
- Debt to Equity (x)
- 0.11x
- Interest Coverage (x)
- -8.58x
- 2.22x
- Revenue Growth %
- 54.08%
- Operating Profit Growth %
- 35.70%
- Net Profit Growth %
- 21.83%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- -3.73
- Book Value (₹)
- 55.15
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -2.89
- Operating Margin %
- -7.84%
- Net Margin %
- -9.24%
- ROE %
- -8.07%
- ROCE %
- -5.71%
- -5.96%
- Debtor Days
- 26
- Inventory Days
- 59
- Payable Days
- 39
- 47
- Debt to Equity (x)
- 0.07x
- Interest Coverage (x)
- -13.69x
- 3.35x
- Revenue Growth %
- 19.91%
- Operating Profit Growth %
- 31.04%
- Net Profit Growth %
- 48.45%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- -11.81
- Book Value (₹)
- 43.23
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -11.60
- Operating Margin %
- -14.93%
- Net Margin %
- -19.51%
- ROE %
- -27.39%
- ROCE %
- -23.50%
- -18.25%
- Debtor Days
- 10
- Inventory Days
- 50
- Payable Days
- 22
- 39
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- -13.01x
- 3.34x
- Revenue Growth %
- 37.90%
- Operating Profit Growth %
- -162.48%
- Net Profit Growth %
- -191.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- -12.20
- Book Value (₹)
- 64.48
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -14.85
- Operating Margin %
- -13.36%
- Net Margin %
- -13.53%
- ROE %
- -30.43%
- ROCE %
- -31.37%
- -19.05%
- Debtor Days
- 11
- Inventory Days
- 52
- Payable Days
- 32
- 31
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- -38.31x
- 2.18x
- Revenue Growth %
- 75.41%
- Operating Profit Growth %
- -56.99%
- Net Profit Growth %
- -21.63%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- -3.27
- Book Value (₹)
- 61.27
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -3.97
- Operating Margin %
- -1.69%
- Net Margin %
- -3.12%
- ROE %
- -8.55%
- ROCE %
- -6.48%
- -5.62%
- Debtor Days
- 9
- Inventory Days
- 51
- Payable Days
- 33
- 28
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- -5.27x
- 2.31x
- Revenue Growth %
- 42.23%
- Operating Profit Growth %
- 81.97%
- Net Profit Growth %
- 67.21%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 197.04
- Book Value (₹)
- 258.25
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 273.26
- Operating Margin %
- -5.59%
- Net Margin %
- 137.01%
- ROE %
- 170.23%
- ROCE %
- 214.79%
- 110.18%
- Debtor Days
- 10
- Inventory Days
- 55
- Payable Days
- 22
- 43
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 333.22x
- 7.72x
- Revenue Growth %
- 15.18%
- Operating Profit Growth %
- -280.42%
- Net Profit Growth %
- 5161.50%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- -22.70
- Book Value (₹)
- 235.27
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -28.69
- Operating Margin %
- -1.85%
- Net Margin %
- -9.57%
- ROE %
- -12.67%
- ROCE %
- -15.23%
- -8.02%
- Debtor Days
- 10
- Inventory Days
- 52
- Payable Days
- 17
- 44
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- -62.15x
- 4.52x
- Revenue Growth %
- 64.68%
- Operating Profit Growth %
- 45.48%
- Net Profit Growth %
- -111.50%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 2.79
- Book Value (₹)
- 238.09
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.71
- Operating Margin %
- 0.40%
- Net Margin %
- 0.43%
- ROE %
- 0.78%
- ROCE %
- -3.88%
- 0.50%
- Debtor Days
- 9
- Inventory Days
- 39
- Payable Days
- 15
- 34
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- -27.52x
- 7.53x
- Revenue Growth %
- 32.30%
- Operating Profit Growth %
- 442.18%
- Net Profit Growth %
- 105.88%
- 112.30%
- P/E (x)
- 108.60x
- P/B (x)
- 1.27x
- Dividend Yield %
- 0.00%
- 13.93x
Mar 2025
- EPS (₹)
- -28.66
- Book Value (₹)
- 210.58
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -40.15
- Operating Margin %
- -5.04%
- Net Margin %
- -12.02%
- ROE %
- -18.71%
- ROCE %
- -28.40%
- -12.64%
- Debtor Days
- 7
- Inventory Days
- 37
- Payable Days
- 18
- 26
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- -694.10x
- 5.71x
- Revenue Growth %
- -19.25%
- Operating Profit Growth %
- -94.10%
- Net Profit Growth %
- -2381.77%
- -1126.34%
- P/E (x)
- 0.00x
- P/B (x)
- 1.15x
- Dividend Yield %
- 0.00%
- 195.23x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-17 - Health X Platform Limited has informed the Exchange about Transcript
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-11 - Health X Platform Limited has informed the Exchange about Link of Recording
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
Jun 2026
Feb 2026